Bioreactors can be used to deliver cytokines and other bioactive molecules for the control of SM differentiation (Liuetal

Bioreactors can be used to deliver cytokines and other bioactive molecules for the control of SM differentiation (Liuetal. 2013). 3 months after infarction. Electrical activity in the healthy and infarction zones from the heart was examinedex vivoin Langendorff-perfused hearts by optical mapping using di-4-ANEPPS, a potential sensitive fluorescent dye. We demonstrate that SMs in the coculture can couple electrically not only to abutted but also to remote acutely isolated allogenic cardiac myocytes through membranous tunnelling tubes. The beneficial effect of cellular therapy on LVEF and electric activity was observed in the group of animals injected with Cx43EGFP-expressing SMs. L-type Ca2+current amplitude was approximately fivefold smaller in the isolated SMs compared to healthy myocytes suggesting that limited recovery of LVEF may be related to inadequate expression or function of L-type Ca2+channels in transplanted differentiating SMs. Keywords: 2D echocardiography, autologous skeletal myoblast transplantation, connexin43, intercellular communication, myocardial infarction, optical mapping Ischaemic heart disease and myocardial infarction (MI) lead among the major causes of mortality globally. Heart failure following MI results from acute loss of myocytes in the infarction zone and pathologic remodelling of the ventricle. In creature models, the experimental MI causes death of 530% of the myocytes in the heart (Mani & Kitsis2003). Because natural mechanisms of heart self-renewal possess a low potential, the replacement of lost cardiomyocytes (CMs) is the main goal of heart regeneration. Among a number of other types of stem cells considered intended for regeneration from the heart (reviewed in Henning2011; Shah and Shalia2011; Hassanet al. 2014), autologous skeletal myoblasts (SMs) are acceptable candidates due to their high proliferative potential, resistance to ischaemia, easy isolation from muscle biopsy, and absence of tumorigenicity, immunological and ethical concerns. Creature studies have shown a positive effect of autologous SM transplantation on heart function (Durraniet al. 2010; Kolanowskiet al. 2014), but the data obtained from phase I clinical trials, which failed to demonstrate functionally effective heart regeneration after infarction, are controversial (Menascheet TG-02 (SB1317) al. 2008; Seidelet al. 2009; Brickwedelet al. 2014). The efficiency of SMs can be improved using cells overexpressing prosurvival genes (such because Akt) or angiogenesis-initiating genes (such because vascular endothelial growth factor) (Mangiet al. 2003; Haideret al. 2004) or preconditioning SMs with growth factors (Kofidiset al. 2004; Kanemitsuet al. 2006; Haideret al. 2008; Haider & Ashraf2009). As donor cell death in the cardiac muscle is mainly caused by oxidative stress and inflammation, heat treatment has also been shown to contribute to the improvement from the efficiency of stem cell therapy (Suzukiet al. 2000; Nakamuraet al. 2006; Kojimaet al. 2007; Yanget al. 2007). Our recent study has demonstrated that in SMs, hyperthermia may stimulate the expression of total Cx43 protein and improve COL12A1 gap junction (GJ) function (Antanaviciuteet al. 2014a). The main disadvantage of SM application is an increased risk of ventricular tachyarrhythmias (Fernandeset al. 2006; Shermanet al. 2009). The pathogenesis of these arrhythmias is poorly understood. One of the reasons may be downregulation of endogenous GJ protein connexin43 (Cx43) during SM differentiation (Baloghet al. 1993; Reineckeet al. 2000; Menasche2009). It has been shown by other authors that transplanted SMs cannot transdifferentiate into CMs and are committed to form the skeletal muscle in the heart (Murryet al. 1996; Reineckeet al. 2002). Implanted SMs proliferate up to three or more days and then differentiate to form multinucleated myotubes without electromechanical coupling between host CMs because the expression of two key proteins, N-cadherin and connexin, which are involved in electromechanical cell integration, is downregulatedin vivo(Reineckeet al. 2000; Leobonet al. 2003). Cx43 is the most abundant GJ protein in the ventricular myocardium responsible for electric and metabolic communication between CMs. Therefore , the overexpression of TG-02 (SB1317) Cx43 could be a useful strategy to improve the therapeutic benefit of SMs. For example , enhanced GJ formation between SMs TG-02 (SB1317) and CMs and decreased arrhythmogenicity were noticed when SMs overexpressing Cx43 were transplanted into the heart (Abrahamet al. 2005; Roellet al. 2007; Kolanowskiet al. 2014). However , in the study by Fernandeset al. (2009) improved electric coupling after implantation of SMs expressing exogenous Cx43 was not adequate to prevent ventricular arrhythmias. The benefit is associated with efficient electric incorporation of engrafted cells into the infarcted myocardium where the majority of myocytes are lost. It.